1. The Nobel Prize. Nobel Prize Laureates. Available from: https://www.nobelprize.org/ [Accessed: December 26, 2022]
2. Vlasova-St. Louis I, Abadie J. Prophylactic ribonucleic acid vaccines to combat rna viral infections in humans. In: RNA Therapeutics - History, Design, Manufacturing, and Applications. London, UK: IntechOpen; 2022. pp. 14-38
3. AIM ImmunoTech. As Rintatolimod Moves Closer to Clinical Approval, What is the Likelihood that the Drug will be Approved?. Available from: https://www.pharmaceutical-technology.com/data-analysis/rintatolimod-what-is-the-likelihood-that-drug-will-be-approved/ [Accessed: December 30, 2022]
4. Martínez T, Jiménez AI, Pañeda C. Short-interference RNAs: Becoming medicines. EXCLI Journal. 2015;14:714-176
5. Veiga N, Goldsmith M, Diesendruck Y, et al. Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target. Journal of Controlled Release. 2019;313:33-41